Why is Amdocs stock cratering 40% today?
Amdocs stock fell 39.4% to $37.83 after issuing a weak fiscal 2027 outlook due to a legal dispute with T-Mobile, its largest customer. Q4 2026 results met expectations, but FY2027 revenue is projected to decline 14.3%-17.9% and adjusted EPS to fall 26%-30%. Oppenheimer downgraded the stock, and analysts revised earnings forecasts downward. The company also announced a $340M acquisition, adding to financial pressures.
How this was made
The 30-second read
Why it matters
The guidance cut and downgrade suggest near‑term earnings pressure, prompting a steep pre‑market sell‑off.
Market read
Amdocs' stock fell ~40% on news of a severe guidance downgrade and a high‑profile customer dispute, creating immediate trading opportunity.
What to watch
The $340 M acquisition of EIS may provide long‑term upside once integration progresses.
Background
Amdocs reported FY2026 Q4 results in line with expectations but issued a markedly weaker FY2027 outlook amid a legal battle with its largest U.S. customer, T‑Mobile.
Ticker impact
Amdocs disclosed FY2027 revenue down 14.3%-17.9% and EPS down 26%-30% plus a T‑Mobile legal dispute, triggering a 39.4% pre‑market plunge.
likely further downside pressure as the market prices in weaker outlook and dispute risk.
The guidance revision is material, the stock already fell 39% pre‑open, and no mitigating news was provided.
Market effects
Amdocs' decline highlights exposure risk for telecom‑software vendors reliant on a few large carriers.
U.S. equities may see modest drag despite broader index gains.
Limited to U.S. tech and telecom sectors.
Counterpoint
If the T‑Mobile dispute resolves favorably, the stock could rebound sharply from oversold levels.
Key entities
- CompanyAmdocs
U.S. software provider for telecom operators.
- CompanyT‑Mobile
Amdocs' largest North American customer.


